Roadzen director granted 152,732 stock options
Roadzen Inc. director Supurna VedBrat reported receiving a new stock option grant.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Roadzen Inc. director Supurna VedBrat reported receiving a new stock option grant. On 09/15/2025, VedBrat was granted a stock option to buy 152,732 Roadzen ordinary shares at an exercise price of $2.00 per share. The option became exercisable on 09/15/2025 and will expire on 09/15/2032. Following this grant, VedBrat beneficially owned 152,732 derivative securities directly.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Stock Option (right to buy) | 152,732 | $0.00 | $0.00 |
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What insider transaction did Roadzen (RDZN) disclose in this Form 4?
What is the exercise price of the Roadzen (RDZN) stock options granted to Supurna VedBrat?
When do Supurna VedBrat’s Roadzen stock options vest and expire?
How many Roadzen derivative securities does Supurna VedBrat own after this transaction?
What is Supurna VedBrat’s relationship to Roadzen Inc.?
Was this Roadzen (RDZN) Form 4 filed for a derivative or non-derivative security?
AI-generated analysis. How Rhea-AI works. Not financial advice.